vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $23.1M, roughly 1.0× ADC Therapeutics SA). On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs 36.4%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

ADCT vs PED — Head-to-Head

Bigger by revenue
PED
PED
1.0× larger
PED
$23.1M
$23.1M
ADCT
Growing faster (revenue YoY)
PED
PED
+81.9% gap
PED
118.2%
36.4%
ADCT
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
PED
PED
Revenue
$23.1M
$23.1M
Net Profit
$-8.5M
Gross Margin
Operating Margin
-77.7%
-21.3%
Net Margin
-36.8%
Revenue YoY
36.4%
118.2%
Net Profit YoY
-243.5%
EPS (diluted)
$0.04
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
PED
PED
Q4 25
$23.1M
$23.1M
Q3 25
$15.8M
$7.0M
Q2 25
$18.1M
$7.0M
Q1 25
$17.4M
$8.7M
Q4 24
$16.9M
$10.6M
Q3 24
$18.0M
$9.1M
Q2 24
$17.0M
$11.8M
Q1 24
$17.8M
$8.1M
Net Profit
ADCT
ADCT
PED
PED
Q4 25
$-8.5M
Q3 25
$-41.0M
$-325.0K
Q2 25
$-56.6M
$-1.7M
Q1 25
$-38.6M
$140.0K
Q4 24
$5.9M
Q3 24
$-44.0M
$2.9M
Q2 24
$-36.5M
$2.7M
Q1 24
$-46.6M
$773.0K
Operating Margin
ADCT
ADCT
PED
PED
Q4 25
-77.7%
-21.3%
Q3 25
-196.6%
-12.0%
Q2 25
-244.1%
-32.2%
Q1 25
-163.5%
1.7%
Q4 24
-191.8%
-12.9%
Q3 24
-197.4%
31.3%
Q2 24
-170.5%
22.3%
Q1 24
-188.3%
7.6%
Net Margin
ADCT
ADCT
PED
PED
Q4 25
-36.8%
Q3 25
-260.1%
-4.7%
Q2 25
-313.2%
-24.0%
Q1 25
-221.8%
1.6%
Q4 24
56.0%
Q3 24
-244.1%
32.2%
Q2 24
-214.6%
22.7%
Q1 24
-261.1%
9.5%
EPS (diluted)
ADCT
ADCT
PED
PED
Q4 25
$0.04
$-2.23
Q3 25
$-0.30
$0.00
Q2 25
$-0.50
$-0.02
Q1 25
$-0.36
$0.00
Q4 24
$-0.26
$2.69
Q3 24
$-0.42
$0.03
Q2 24
$-0.38
$0.03
Q1 24
$-0.56
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
PED
PED
Cash + ST InvestmentsLiquidity on hand
$261.3M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$207.4M
Total Assets
$323.1M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
PED
PED
Q4 25
$261.3M
$3.2M
Q3 25
$234.7M
$10.9M
Q2 25
$264.6M
$8.5M
Q1 25
$194.7M
$10.4M
Q4 24
$250.9M
$4.0M
Q3 24
$274.3M
$4.6M
Q2 24
$300.1M
$6.1M
Q1 24
$234.3M
$13.3M
Stockholders' Equity
ADCT
ADCT
PED
PED
Q4 25
$-185.8M
$207.4M
Q3 25
$-238.2M
$115.4M
Q2 25
$-199.2M
$115.2M
Q1 25
$-238.2M
$116.2M
Q4 24
$-202.6M
$115.6M
Q3 24
$-171.9M
$106.5M
Q2 24
$-131.7M
$103.2M
Q1 24
$-194.4M
$100.0M
Total Assets
ADCT
ADCT
PED
PED
Q4 25
$323.1M
$375.9M
Q3 25
$289.8M
$135.9M
Q2 25
$321.6M
$136.8M
Q1 25
$272.5M
$145.6M
Q4 24
$322.0M
$128.3M
Q3 24
$349.1M
$114.3M
Q2 24
$371.8M
$111.0M
Q1 24
$308.0M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
PED
PED
Operating Cash FlowLast quarter
$-31.1M
$-2.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
PED
PED
Q4 25
$-31.1M
$-2.1M
Q3 25
$-29.6M
$7.4M
Q2 25
$-24.1M
$-420.0K
Q1 25
$-56.3M
$5.9M
Q4 24
$-21.9M
$4.2M
Q3 24
$-25.0M
$8.3M
Q2 24
$-32.8M
$4.6M
Q1 24
$-44.1M
$-4.3M
Free Cash Flow
ADCT
ADCT
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
Q3 24
$-25.3M
Q2 24
$-32.9M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
Q3 24
-140.2%
Q2 24
-193.0%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
PED
PED
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
Q3 24
1.2%
Q2 24
0.2%
Q1 24
3.0%
Cash Conversion
ADCT
ADCT
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons